Loading…
skip to main content
Inflammatory Breast Cancer

Inflammatory breast cancer is an uncommon type of breast cancer in which breast cancer cells block the lymph vessels in the skin of the breast. This blockage may cause the breast to become red, swollen, and warm. The skin of the breast may also appear pink, purple, or bruised, and it may have ridges or appear pitted, like the skin of an orange (called peau d'orange). These changes often occur quickly over a period of weeks. Another possible sign of this type of breast cancer is swollen lymph nodes under the arm, above the collarbone, or in both places. Often, a tumor cannot be felt, and may not be seen on a mammogram. The diagnosis of inflammatory breast cancer is based on the results of the biopsy and the doctor's clinical judgment.

Inflammatory breast cancer generally grows rapidly, and the cancer cells often spread to other parts of the body. A woman with inflammatory breast cancer usually has local treatment to remove or destroy the cancer in the breast and systemic treatment to control or kill cancer cells that may have spread to other parts of the body. Local treatment affects only cells in the tumor and the area close to it; systemic treatment affects cells throughout the body. The local treatment may be surgery and/or radiation therapy to the breast and underarm. The systemic treatment may be chemotherapy (anticancer drugs), hormonal therapy (drugs that interfere with the effects of the female hormone estrogen), or both. Systemic treatment is generally given before surgery and/or radiation therapy. In some cases, local treatment may be followed by additional systemic treatment with hormonal therapy, chemotherapy, or both. Some women also may have biological therapy (which stimulates the immune system to fight the cancer).

Researchers continue to study the effectiveness of biological therapy, new chemotherapy and hormonal therapy, and new combinations of chemotherapy and hormonal therapy. Information about ongoing clinical trials (research studies) is available from the Cancer Information Service (see below), or from the clinical trials page of the National Cancer Institute's (NCI) Cancer.gov Web site at http://cancer.gov/clinical_trials on the Internet.

Source: National Cancer Institute
Date reviewed: 05/06/2003



Medical/Legal Disclaimer

MON97

Last Updated: Jun 3rd, 2009

Keywords

Nucleus Medical Media Disclaimer of Medical and Legal Liability

Nucleus Medical Media ("Nucleus") does not dispense medical or legal advice, and the text, illustrations, photographs, animations and other information ("Content") available on this web site is for general information purposes only. As with any medical or legal issue, it is up to you to consult a physician or attorney for professional advice. YOU SHOULD NOT DISREGARD PROFESSIONAL MEDICAL OR LEGAL ADVICE BASED ON CONTENT CONTAINED ON THIS WEB SITE, NOR SHOULD YOU RELY ON THE CONTENT ON THIS WEB SITE IN PLACE OF PROFESSIONAL MEDICAL OR LEGAL ADVICE.

NUCLEUS DISCLAIMS ALL RESPONSIBILITY AND LIABILITY FOR ANY COUNSEL, ADVICE, TREATMENT, DIAGNOSIS OR ANY MEDICAL, LEGAL OR OTHER INFORMATION, SERVICES OR PRODUCTS THAT YOU OBTAIN BASED ON VIEWING THE CONTENT OF THIS SITE. THE INFORMATION ON THIS WEB SITE SHOULD NOT BE CONSIDERED COMPLETE OR SUITABLE FOR ANY PURPOSE WHATSOEVER.

Mature Content Disclaimer: Certain Content on this web site contains graphic depictions or descriptions of medical information, which may be offensive to some viewers. Nucleus, its licensors, and its suppliers disclaim all responsibility for such materials.

close